Literature DB >> 6199212

Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.

H Pircher, G Hämmerling, H Hengartner.   

Abstract

The cell-mediated cytotoxic response against autologous cells modified with the sulfhydryl reagent I-AED [N-iodo-acetyl-N-(5-sulfonic-1-naphthyl) ethylene diamine] has been described by Levy, R. B., Shearer, G. M., Richardson, J. C. and Henkart, P. A., [J. Immunol. 1981. 127: 523.]. We have established two H-2Db- and eight H-2Kb-restricted, AED-specific long-term cytotoxic T lymphocyte (CTL) clones of C57BL/10 origin. The growth of these clones has been dependent upon presence of both antigen and interleukin 2. Cytotoxicity and proliferation analysis of AED-specific Kb-restricted CTL clones with target and stimulator cells from Kbm-mutant mice demonstrated two categories of clones (A and B) based on different reactivity patterns against hapten-modified Kbm-mutant cells. AED-modified target cells of bm5, bm6 and bm9 origin were lysed by type A clones but not by type B clones, in contrast to AED-modified bm3, bm8 and bm11 target cells which were lysed by type B but not by type A clones. None of the clones lysed AED-modified bm1 target cells, but all of them lysed AED-modified bm4 and bm10 target cells. The restriction fine specificities for both cytolytic and proliferative activities of the analyzed clones were identical. A panel of monoclonal antibodies (mAb) directed against the Kb molecule was used to inhibit lysis of AED-modified target cells by CTL clones. mAb which recognize a cluster of allodeterminants located in the second external domain (C1 domain) of the Kb molecule [Hämmerling, G. J., Rüsch, E., Tada, N., Kimura, S. and Hämmerling, U., Proc. Natl. Acad. Sci. USA 1982. 79: 4737] only inhibited type B clones, whereas inhibition of both type of clones was observed with mAb specific for allodeterminants clustered in the N-terminal region of Kb. These findings suggest that different regions on the Kb molecule serve as self determinants for H-2-restricted cytotoxicity. We also demonstrate that allodeterminants recognized by mAb and self determinants involved in H-2 restriction need not be identical. Our data also support the notion that covalent AED modification of H-2 molecules is not necessary to generate the self plus X antigen for CTL recognition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199212     DOI: 10.1002/eji.1830140208

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor.

Authors:  J Payne; B T Huber; N A Cannon; R Schneider; M W Schilham; H Acha-Orbea; H R MacDonald; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

2.  Cloned cytotoxic T cells specific for lymphocytic choriomeningitis virus induce acute disease and primary footpad swelling in infected mice.

Authors:  J Baenziger; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.

Authors:  K L Rosenthal; R M Zinkernagel; H Hengartner; P Groscurth; G Dennert; D Takayesu; L Prevec
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  T cell receptor variable gene usage in a specific cytotoxic T cell response. Primary structure of the antigen-MHC receptor of four hapten-specific cytotoxic T cell clones.

Authors:  A Iwamoto; P S Ohashi; H Pircher; C L Walker; E E Michalopoulos; F Rupp; H Hengartner; T W Mak
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

5.  T cell-specific gamma genes in C57BL/10 mice. Sequence and expression of new constant and variable region genes.

Authors:  A Iwamoto; F Rupp; P S Ohashi; C L Walker; H Pircher; R Joho; H Hengartner; T W Mak
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.